BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27063470)

  • 1. Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma.
    López JI; Errarte P; Erramuzpe A; Guarch R; Cortés JM; Angulo JC; Pulido R; Irazusta J; Llarena R; Larrinaga G
    Hum Pathol; 2016 Aug; 54():100-5. PubMed ID: 27063470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
    Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C
    J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
    Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma.
    Can C; Acikalin MF; Ozen A; Dundar E
    Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T
    Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
    Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
    Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases.
    Errarte P; Guarch R; Pulido R; Blanco L; Nunes-Xavier CE; Beitia M; Gil J; Angulo JC; López JI; Larrinaga G
    PLoS One; 2016; 11(12):e0169105. PubMed ID: 28033421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
    Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
    Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
    Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
    Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
    Calvete J; Larrinaga G; Errarte P; Martín AM; Dotor A; Esquinas C; Nunes-Xavier CE; Pulido R; López JI; Angulo JC
    Hum Pathol; 2019 Sep; 91():61-68. PubMed ID: 31279874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell papillary renal cell carcinoma: a clinicopathologic analysis of 6 cases.
    Yan WX; Cao WR; Zhao J; Zhang W; Wang XL; Yuan Q; Dang SQ
    Int J Clin Exp Pathol; 2015; 8(5):4595-9. PubMed ID: 26191150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.
    Ronkainen H; Vaarala MH; Kauppila S; Soini Y; Paavonen TK; Rask J; Hirvikoski P
    Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
    Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
    Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).
    Abbas M; Steffens S; Bellut M; Eggers H; Großhennig A; Becker JU; Wegener G; Schrader AJ; Grünwald V; Ivanyi P
    Med Oncol; 2016 Jul; 33(7):80. PubMed ID: 27317388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.
    Osman WM; Youssef NS
    Int J Clin Exp Pathol; 2015; 8(7):8165-77. PubMed ID: 26339385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
    Abbas O; Richards JE; Mahalingam M
    Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.